Guo et al. showed that the activation of the NF-κB pathway by expression of TLR adaptor molecules (MyD88, TRIF, or IPS-1) in hepatoma cells suppresses HBV replication and transcription29. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.